Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Samsca

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Alkem Lab’s Generics Tolvaptan Receives Tentative Approval in US
    Alkem Lab’s Generics Tolvaptan Receives Tentative Approval in US

    17 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220147

    FDA
    17 Oct 2025
    Share Share
    Lupin launches Tolvaptan Tablets in the US
    Lupin launches Tolvaptan Tablets in the US

    14 May 2025

    // EXPRESS PHARMA

    https://www.expresspharma.in/lupin-launches-tolvaptan-tablets-in-the-us/

    EXPRESS PHARMA
    14 May 2025
    Share Share
    Lupin receives US FDA approval for generic Tolvaptan Tablets
    Lupin receives US FDA approval for generic Tolvaptan Tablets

    25 Apr 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/lupin-receives-us-fda-approval-for-generic-tolvaptan-tablets/

    EXPRESSPHARMA
    25 Apr 2025
    Share Share
    Lupin's Generic Tolvaptan Receives Approval in the U.S.
    Lupin's Generic Tolvaptan Receives Approval in the U.S.

    05 Oct 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216063

    FDA
    05 Oct 2023
    Share Share
    Hetero's Generic Tolvaptan Receives Approval in the U.S.
    Hetero's Generic Tolvaptan Receives Approval in the U.S.

    06 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205646

    FDA
    06 Sep 2022
    Share Share
    Apotex's Generic Tolvaptan Receives Approval in the U.S.
    Apotex's Generic Tolvaptan Receives Approval in the U.S.

    06 Sep 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207605

    FDA
    06 Sep 2022
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.